Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › MIRM

EVENTIDE ASSET MANAGEMENT, LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

EVENTIDE ASSET MANAGEMENT, LLC reported holding 1,248,259 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$106.7M, representing 1.50% of its reported portfolio and ranking #9 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.25M sh
Reported value held$106.72M
Portfolio Weight1.50%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How EVENTIDE ASSET MANAGEMENT, LLC's MIRM position evolved

EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in MIRM in Q3 2023 at 3,958,579 shares (US$125.1M). The position peaked in Q3 2025 at 2,522,563 shares, worth US$184.9M. Across 13 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,248,259 shares valued at US$106.7M. Notable position changes include a 33% trim in Q4 2023 (shares fell 15% over the following quarter), a 71% trim in Q2 2024 (shares rose 14% over the following quarter), a 263% increase in Q3 2024 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.96M $125.09M New
Q4 2023 2.66M $78.63M Reduce
Q1 2024 3.30M $82.91M Add
Q2 2024 950.00K $1.28M Reduce
Q3 2024 3.45M $134.37M Add
Q4 2024 2.61M $107.80M Reduce
Q1 2025 2.53M $113.85M Reduce
Q2 2025 2.64M $134.22M Add
Q3 2025 2.52M $184.92M Reduce
Q4 2025 2.09M $165.37M Reduce
Q1 2026 1.41M $130.11M Reduce
Q2 2026 1.25M $146.20M Reduce
Q3 2026 1.25M $106.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), TANG CAPITAL MANAGEMENT LLC (US$144.7M), Novo Holdings A/S (US$131.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has EVENTIDE ASSET MANAGEMENT, LLC held MIRM?

EVENTIDE ASSET MANAGEMENT, LLC has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EVENTIDE ASSET MANAGEMENT, LLC's current position in MIRM?

As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.25M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $106.72M, representing 1.50% of its reported portfolio and ranking #9.

Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling MIRM?

In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC held unchanged its position in MIRM. The position peaked in Q3 2025 at 2.52M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., TANG CAPITAL MANAGEMENT LLC, Novo Holdings A/S, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.